Status:
COMPLETED
Effect of Nasal Steroids in Snoring Intensity
Lead Sponsor:
Ioannis Koutsourelakis
Conditions:
Snoring
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
Brief Summary
It is anecdotally well known that patients snore more when their nose is blocked. However, the therapeutic effect of improving nasal airway patency on snoring indices remains a point of conjecture. In...
Detailed Description
Snoring intensity would be measured using a calibrated microphone-sound meter system. The 2 microphones will be suspended at a distance of 1 m approximately above the surface of the patient's bed. Thi...
Eligibility Criteria
Inclusion
- every night snoring;
- no medication known to influence nasal resistance (e.g., antihistamines, vasoconstrictors, topical or systemic steroids);
- no smoking for the last 6 months;
- no upper or lower respiratory tract disease (e.g., upper respiratory tract infection, rhinitis, sinusitis, chronic obstructive pulmonary disease), including a history of nasal allergy; and
- written informed consent from each patient.
Exclusion
- duration of snoring less than 60 minutes during sleep study, and
- central apnoeas more than five percent of total apnoeas.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01849406
Start Date
April 1 2013
End Date
September 1 2013
Last Update
September 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Critical Care Medicine, Evangelismos Hospital of Athens
Athens, Greece